Ciamexone as a selective immunosuppressant

US5055290A · kind A · utility

Assignee

• Boehringer Mannehim GmbH · DE

Inventors

• Uwe Bicker · Mannheim, DE
• Wulf Pahlke · Bensheim, DE

Key dates

• Filing date: May 25, 1988
• Grant date: Oct 8, 1991
• Expiry date: May 25, 2008

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/44
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of selectively suppressing the excess immune reaction produced iatrogenically or autochthonously by administering 0.1 to 100 mg of ciamexone per kg of body weight.